GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Luyan Pharma Co Ltd (SZSE:002788) » Definitions » Deferred Tax

Luyan Pharma Co (SZSE:002788) Deferred Tax : ¥0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Luyan Pharma Co Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Luyan Pharma Co's change in deferred tax for the three months ended in Mar. 2024 was ¥0 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0 Mil.

Luyan Pharma Co Deferred Tax Historical Data

The historical data trend for Luyan Pharma Co's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Luyan Pharma Co Deferred Tax Chart

Luyan Pharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Luyan Pharma Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Luyan Pharma Co Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Luyan Pharma Co Deferred Tax Related Terms

Thank you for viewing the detailed overview of Luyan Pharma Co's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Luyan Pharma Co (SZSE:002788) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Luyan Pharma Co Ltd (SZSE:002788) » Definitions » Deferred Tax
Comparable Companies
SZSE:002462 SZSE:300937 SZSE:301126 SHSE:600833 SZSE:300108 SZSE:002758 SHSE:605266 SZSE:301408 SZSE:301017 SZSE:002727 WBA BSP:RADL3 HKSE:00241 TSE:3088 SAU:4164 SHSE:603939 TSE:3349 SHSE:600998 HKSE:09885 TSE:3391
Traded in Other Exchanges
N/A
Address
1004 Ridge Road, Huli District, Fujian Province, Xiamen City, CHN, 361 010
Website
http://www.luyan.com.cn
Luyan Pharma Co Ltd, formerly Luyan (Fujian) Pharma Co Ltd engages in the production, operation, distribution, and retail of human health products in China. It provides medical and health products.
Executives
Zhu Ming Guo Executives
Yang Cong Jin Directors, executives
Lei Ming Directors, executives
Li Wei Yang Executives
Cai Mei Zhen Supervisors
Li Cui Ping Supervisors
Wu Jin Xiang Directors, executives
Zhang Jun Ying Executives
Wu Huo Lu Director

Luyan Pharma Co (SZSE:002788) Headlines

No Headlines